Another study using the adriamycin model of FSGS found that loss of decay-accelerating factor (CD55) on podocytes initiates complement C3aR signaling, leading to IL-1β production and subsequent podocyte injury, implicating C3a/C3aR signaling in the pathogenesis of FSGS (41). This evidence concerns the gene CD55 and focal segmental glomerulosclerosis.